MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, LIVN made $362,258K in revenue. $22,294K in net income. Net profit margin of 6.15%.

Income Overview

Revenue
$362,258K
Net Income
$22,294K
Net Profit Margin
6.15%
EPS
$0.4
Unit: Thousand (K) dollars
Revenue Breakdown
    • Cardiopulmonary Segment-Operatin...
    • Neuromodulation Segment-Operatin...
    • Corporate Non Segment
Revenue Breakdown
    • US
    • Locations Excluding The United S...
    • Europe

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net revenue
362,258 360,921 357,753 352,524
Cost of sales
118,509 125,669 112,898 113,536
Gross profit
243,749 235,252 244,855 238,988
Selling, general, and administrative
143,568 138,844 138,522 137,780
Research and development
58,695 52,123 48,577 47,185
Impairment of long-lived assets
-0 --
Other operating expense
-15 -1,707 -3,744 160
Operating income
41,471 42,578 54,012 54,183
Gain on debt extinguishment
-1,326* 0 -2,651
Foreign exchange and other income/(expense)
----4,255
Snia environmental liability expense
0 1,738 1,745 1,677
Interest expense
8,291 10,857 10,863 12,280
Foreign exchange and other income/(expense)
-5,695 -3,674* -7,493 -
Income (gain) before income tax
27,485 27,634 33,911 33,320
Income tax expense
4,340 -3,282 7,114 6,151
Loss from equity method investments
-851 -10 -13 -8
Net income (gain)
22,294 30,906 26,784 27,161
Basic EPS
0.41 0.566 0.49 0.5
Diluted EPS
0.4 0.573 0.49 0.5
Basic Average Shares
54,688,000 54,564,000 54,630,000 54,577,000
Diluted Average Shares
55,944,000 53,910,000 55,153,000 54,708,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Locations Excluding TheUnited States And...$82,072K (15.63%↑ Y/Y)US$69,279K (13.88%↑ Y/Y)Europe$57,304K (28.75%↑ Y/Y)US$115,400K (6.52%↑ Y/Y)Europe$18,348K (20.76%↑ Y/Y)Locations Excluding TheUnited States And...$18,040K (17.41%↑ Y/Y)CardiopulmonarySegment-Operating Segments$208,655K (18.34%↑ Y/Y)NeuromodulationSegment-Operating Segments$151,788K (9.28%↑ Y/Y)Corporate Non Segment$1,815K (10.54%↑ Y/Y)Net revenue$362,258K (14.33%↑ Y/Y)Gross profit$243,749K (10.41%↑ Y/Y)Cost of sales$118,509K (23.34%↑ Y/Y)Operating income$41,471K (-14.70%↓ Y/Y)Selling, general, andadministrative$143,568K (7.41%↑ Y/Y)Research and development$58,695K (54.95%↑ Y/Y)Other operatingexpense-$15K (97.55%↑ Y/Y)Income (gain) beforeincome tax$27,485K (108.71%↑ Y/Y)Interest expense$8,291K (-45.76%↓ Y/Y)Foreign exchange andother...-$5,695K (-149.89%↓ Y/Y)Net income (gain)$22,294K (106.81%↑ Y/Y)Income tax expense$4,340K (-62.77%↓ Y/Y)Loss from equitymethod investments-$851K (-4155.00%↓ Y/Y)

LivaNova PLC (LIVN)

LivaNova PLC (LIVN)